-
Mashup Score: 0Online Event - 6 month(s) ago
Blood fats are key biomarkers for heart, liver, and other diseases, highlighting the importance of lipid metabolism for health. Lipoprotein lipase (LPL) is a key enzyme involved in hydrolyzing triglycerides from circulating lipoproteins in the blood, releasing free fatty acids. Understanding the structural and functional aspects of LPL is crucial, given its significant role in lipid metabolism and related diseases. In this webinar, the speaker will describe experiments that uncovered how LPL interacts
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Online Event - 7 month(s) ago
Measurable residual disease, or MRD (also know n as minimal residual disease), refers to detectable cancer cells that remain in cancer patients after treatment. Even small numbers of these cells, particularly in blood cancers—such as leukemia, lymphoma, or multiple myeloma—may replicate and cause relapse, but unfortunately these rare cells usually can’t be detected by microscopy. Newer, more sensitive assays—such as next-generation sequencing (NGS) and digital PCR (dPCR)—can quantify MRD more precisely,
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #Technology broadcast on Wednesday, 20 September at 12 p.m. ET: Emerging technologies for the detection of measurable residual disease (MRD): NGS and dPCR. Register today: https://t.co/DTjuWdvRhY #Webinars https://t.co/KVvv2W5ytv
-
-
Mashup Score: 2Online Event - 8 month(s) ago
Advocacy in rare disease is complex and challenging, but there are effective methods that advocates can use to communicate with the public. In this panel discussion, experts in communication, public relations, and influencing will discuss strategies and tactics to advance advocacy for rare disease. The discussion will explore how advocates can: Raise awareness on how rare disease impacts individuals and families through social media, events, press releases, storytelling, and community engagement, and by
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
On 8 June 2023, #ScienceWebinars hosted a #technology broadcast ➡️ Advocacy in rare disease: Crafting the public narrative. Did you miss it? Catch it here: https://t.co/AWjtYyJTeL #webinar https://t.co/9Y369LnX8Y
-
-
Mashup Score: 2Online Event - 8 month(s) ago
Across the globe, regulatory landscapes are notoriously complex and difficult to navigate, yet laws regarding human health can literally be a matter of life and death. Diagnosis and treatment remain challenging for the more than 7,000 rare diseases impacting 350 million people worldwide. Policy makers set research funding agendas and make laws, such as the Orphan Drug Act, that can tip the balance on whether drug makers will pursue treatments for rare disease and make them accessible. Advocates play a
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #technology broadcast on Thursday, 31 August at 12 p.m. ET ➡️ Advocacy in rare disease: Working the regulatory angle Register today: https://t.co/vrcEuCfp7E #webinar https://t.co/jyGPtxb108
-
-
Mashup Score: 5Online Event - 8 month(s) ago
The immune system is the body’s premier line of defense against microbial pathogens, yet some microbes are treated as friends instead of foes. The colonization of the human body with microbes is critical to a newborn’s developing immune system and metabolic health, and this dynamic process may impact long-term health as well. Researchers are exploring how the body’s earliest interactions with the mic robiome can misfire, leading to childhood disease. Others are probing the molecular details of how immune
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #technology broadcast on Wednesday, 23 August at 12 p.m. ET ➡️ Learning to coexist: How the interplay between the #microbiome and the immune system impacts human health. Register today: https://t.co/SrckeuxrvE #webinar https://t.co/5AScoQwmD6
-
-
Mashup Score: 2Online Event - 8 month(s) ago
The immune system is the body’s premier line of defense against microbial pathogens, yet some microbes are treated as friends instead of foes. The colonization of the human body with microbes is critical to a newborn’s developing immune system and metabolic health, and this dynamic process may impact long-term health as well. Researchers are exploring how the body’s earliest interactions with the mic robiome can misfire, leading to childhood disease. Others are probing the molecular details of how immune
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #technology broadcast on Wednesday, 23 August at 12 p.m. ET ➡️ Learning to coexist: How the interplay between the #microbiome and the immune system impacts human health. Register today: https://t.co/j12XuVm7NQ #webinar https://t.co/o6cTtpcU96
-
-
Mashup Score: 3Online Event - 9 month(s) ago
Advances in our understanding of biology—in particular how living cells function—have enabled us to recruit different types of cells for production of new medicines, new materials, new food ingredients, and even biofuels. This field is referred to as synthetic biology. The roots of synthetic biology were laid in the mid-seventies, with the first molecular cloning and amplification of DNA in a plasmid, known as recombinant DNA. I n 2010 researchers at the J. Craig Venter Institute created the first synthetic
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next broadcast on 2 August at 12 p.m. ET: Rewiring #Biology: #SyntheticBiology innovation in human health. Register today: https://t.co/SVFtch8Zan #webinar https://t.co/Nw8Qh04squ
-
-
Mashup Score: 2Online Event - 10 month(s) ago
Check this box to agree to receive occasional email or other contact from the sponsor of this webinar about their programs, products, services and other offerings. The sponsor agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time by contacting the sponsor. Check this box to agree to receive occasional…
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars as they present their next #webinar on 21 June at 12 p.m. ET ➡️ Seeing the whole picture: Applying #SpatialBiology to immuno-oncology. Register: https://t.co/4fRV2isDWB #CancerResearch https://t.co/zPA9s5C0DV
-
-
Mashup Score: 1Online Event - 11 month(s) ago
In 2017, 64 years after the publication of the structure of DNA, the first gene therapy became clinically available in the United States, a treatment for a sight-robbing eye disease. A year later, chimeric antigen receptor (CAR)-T cell therapy became available. These immune system cells are genetically modified to target therapy-resistant cancers. A handful more cell and gene therapies for a…
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #webinar broadcast live on 14 June at 12 p.m. ET ⬇️ Go with the flow: Advancing cell and #GeneTherapy with #FlowCytometry Register today ➡️ https://t.co/X4wAgHMtI4 https://t.co/i8dmFkNhxG
-
-
Mashup Score: 6Online Event - 11 month(s) ago
Check this box to agree to receive occasional email or other contact from the sponsor of this webinar about their programs, products, services and other offerings. The sponsor agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time by contacting the sponsor. Check this box to agree to receive occasional…
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
It's not too late! Join #ScienceWebinars tomorrow at 12 p.m. E.T. for ➡️ A transfer of power: The cell-to-cell exchange of #mitochondria in #obesity and #aging. Learn more: https://t.co/GmyHGjiDsf #webinar https://t.co/udpidLljLq
-
Join #ScienceWebinars for their next #Technology broadcast on Wednesday, 18 October at 12 p.m ET ➡️ A fresh look at fat metabolism: Studying lipoprotein lipase oligomerization dynamics with #cryoEM and mass photometry. Register today: https://t.co/URiw43ct6F https://t.co/Ohxjtjs5Sp